Asenapine Maleate Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 5 mg, 10 mg
Reference Brands: Saphris (USA)
Category:
Antipsychotropic Drugs
Asenapine Maleate is available in Tablets
and strengths such as 5 mg, 10 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Asenapine Maleate is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Asenapine Maleate can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Asenapine maleate is an atypical antipsychotic medication used for the treatment of schizophrenia and for the acute and long-term management of bipolar I disorder in adults. It is effective in controlling acute manic or mixed episodes associated with bipolar disorder, with or without psychotic features. Asenapine helps stabilize mood and reduce psychotic symptoms such as hallucinations, delusions, and severe mood swings by modulating dopamine and serotonin receptor activity in the brain.
Chemically, asenapine is derived from modifications of the tetracyclic antidepressant mianserin, resulting in a potent atypical antipsychotic profile with improved efficacy and tolerability. It is administered sublingually, allowing rapid absorption and onset of action. Approved by the FDA, asenapine is indicated for both acute treatment phases and maintenance therapy in adults with schizophrenia or bipolar I disorder. Its unique pharmacological properties make it a valuable option for managing complex psychiatric conditions while supporting adherence through convenient sublingual administration.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing